Top of this page
Skip navigation, go straight to the content

Newsroom Overview

Newsroom

Press Release

UCB’s Key Pipeline Molecule Bimekizumab Demonstrated Improved Outcomes for Ankylosing Spondylitis Patients13 Jun 2019

UCB’s Key Pipeline Molecule Bimekizumab Demonstrated Improved Outcomes for …

Read more
Transparency notifications BlackRock, Inc.12 Jun 2019

Transparency notifications BlackRock, Inc.

Read more
UCB Showcases the Depth of its Immunology Research and Commitment to Patients at EULAR 201906 Jun 2019

UCB Showcases the Depth of its Immunology Research and Commitment …

Read more

UCB Stories

Picture of a Brain 20 Jun 2019

Cognitive impairment research: pushing the boundaries of neuroscience …

Read more
General picture of innovation 18 Jun 2019

Investing in innovation: why UCB Ventures backs cutting-edge science …

Read more
Picture of lab equipment 14 Jun 2019

UCB takes the lead for her at EULAR and WCD

Read more

Social Media